Trial Profile
Clinical Trials Insight: 700008655
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2005
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 22 Nov 2005 New trial record.